首頁
Tarsus Pharmaceuticals, Inc.

3月 2026Tarsus Pharmaceuticals, ...的市場佔有率分析

Interested in a career at Tarsus?

健康 > 生物技術和製藥

域名tarsusrx.com

成立年份2017

僱員201 - 500

年度營收$200M - $500M

Tarsus Pharmaceuticals, Inc.

Tarsus Pharmaceuticals, Inc.（包含公司地區）

tarsusrx.com

查看更多網站流量與參與度資訊

Tarsus Pharmaceuticals, Inc.截至 3月 2026 的總收入為 200M - 500M

Tarsus Pharmaceuticals, Inc. 熱門網域產生的總收入

Tarsus Pharmaceuticals, Inc. 熱門網域 3 年內的總收入

Tarsus Pharmaceuticals, Inc. 熱門網域的總收入

tarsusrx.com200M - 500M

透過銷售情報查看更多內容

Tarsus Pharmaceuticals, Inc.的熱門網域總造訪量

了解Tarsus Pharmaceuticals, Inc.市場觸達率與潛在市場影響力。

過去 3 個月的訪問總量

子公司細目

tarsusrx.com38.3K

透過銷售情報查看更多內容

Tarsus Pharmaceuticals, Inc.的熱門網域平均造訪時長

分析Tarsus Pharmaceuticals, Inc.參與度指標。

過去 3 個月平均造訪時長

子公司細目

tarsusrx.com00:01:45

透過銷售情報查看更多內容

Tarsus Pharmaceuticals, Inc.的熱門網域平均頁面瀏覽量

了解Tarsus Pharmaceuticals, Inc.如何保持使用者的參與度、培養其興趣，並鼓勵他們採取下一步。

過去 3 個月平均頁面瀏覽量

子公司細目

tarsusrx.com3.49

透過銷售情報查看更多內容

Tarsus Pharmaceuticals, Inc.按網域劃分的熱門競爭對手

3月 2026的熱門類似網站，依相似度排名

jnjinnovation.com公司名JNJInnovation僱員201 - 500總部英國, Cambridge年度營收$75M - $100M訪問總量40.6K健康 > 生物技術和製藥

使用的熱門技術Tarsus Pharmaceuticals, Inc.

这些是Tarsus Pharmaceuticals, Inc.顶级域名使用的行业网站技术

付費廣告 (5)

PubMatic

轉換與分析 (4)

Google Analytics

電子郵件服務 (4)

G Suite

社群 (4)

Instagram

更多技術

12

檢視所有

新聞與訊號來自Tarsus Pharmaceuticals, Inc.

透過 Similarweb 銷售訊號提醒，每當目標受眾出現新的機會或威脅時，你就會收到每日更新的已識別購買訊號。

新聞Tarsusrx hired Katherine H. (Kate) Goodrich as Board of Directors on Nov 13th '24.IRVINE, Calif., Nov. 13, 2024 (GLOBE NEWSWIRE) - Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care, today announced the appointment of Katherine H. (Kate) Goodrich, M.D., MHS, Chief Medical Officer of Humana Inc., to its Board of Directors.

新聞Tarsusrx hired Elizabeth Yeu as Chief Medical Officer on Nov 4th '24.IRVINE, Calif., Nov. 05, 2024 (GLOBE NEWSWIRE) - Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to address unmet medical needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care, today announced the appointment of Elizabeth Yeu, M.D., as Chief Medical Officer, effective November 4, 2024.

新聞Pharmakon Advisors, LP invests into Tarsusrx $200M.Meanwhile, Tarsus in April picked up $200 million in financing from Pharmakon Advisors, on top of the $180 million equity offering the company pulled off earlier in the year.